Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Officials Could Face Hearings, “Zeroed Out” Salaries, DeLauro Threatens

This article was originally published in The Tan Sheet

Executive Summary

FDA center directors and heads of offices could face zeroed-out salaries in fiscal 2008 as a consequence of failure to follow through on safety investigations, House Appropriations Agriculture Subcommittee Chairwoman Rosa DeLauro says

You may also be interested in...

FDA 2007 Appropriations For Food, Drug Centers Outstrip Bush Request

FDA's Center for Drug Evaluation and Research and related activities are funded at $567.59 million for fiscal 2007 under the continuing resolution passed by Congress Feb. 14 and signed into law Feb. 15

Safe Food Act Would Combine CFSAN, USDA Food Duties Under New Agency

The Government Accountability Office's recent recommendations to consolidate food safety responsibilities into one agency lend strength to similar reforms expressed in the Safe Food Act, according to Sen. Richard Durbin, D-Ill., and Congresswoman Rosa L. DeLauro, D-Conn

Advantage Supplements Seized In FDA-Prompted Raid

FDA followed up on a Sept. 6 seizure of misbranded supplements with a referral of the matter to the U.S. attorney. Food and drug Attorney Marc Ullman applauded the move, saying the use of such referrals will add teeth to agency enforcement actions


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts